genedrive (LON:GDR) Trading 14.1% Higher – What’s Next?

genedrive plc (LON:GDR)’s share price rose 14.1% on Tuesday . The company traded as high as GBX 1.10 and last traded at GBX 1.06. Approximately 5,884,570 shares traded hands during trading, an increase of 52% from the average daily volume of 3,860,514 shares. The stock had previously closed at GBX 0.93.

genedrive Stock Performance

The company has a market capitalization of £11.84 million, a P/E ratio of -1.28 and a beta of -0.04. The business has a 50 day moving average of GBX 0.93 and a 200 day moving average of GBX 0.83. The company has a quick ratio of 5.52, a current ratio of 4.60 and a debt-to-equity ratio of 0.35.

About genedrive

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.